These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7617730)

  • 21. R+-methanandamide inhibits tracheal response to endogenously released acetylcholine via capsazepine-sensitive receptors.
    Nieri P; Martinotti E; Testai L; Adinolfi B; Calderone V; Breschi MC
    Eur J Pharmacol; 2003 Jan; 459(1):75-81. PubMed ID: 12505536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum.
    Cadogan AK; Alexander SP; Boyd EA; Kendall DA
    J Neurochem; 1997 Sep; 69(3):1131-7. PubMed ID: 9282935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of the cannabinoid receptor agonist WIN55212-2 on sympathetic cardiovascular regulation.
    Niederhoffer N; Szabo B
    Br J Pharmacol; 1999 Jan; 126(2):457-66. PubMed ID: 10077239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabinoid receptor agonists inhibit Ca(2+) influx to synaptosomes from rat brain.
    Yoshihara S; Morimoto H; Ohori M; Yamada Y; Abe T; Arisaka O
    Pharmacology; 2006; 76(4):157-62. PubMed ID: 16446560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabinoid CB(1) antagonist SR 141716A attenuates reinstatement of heroin self-administration in heroin-abstinent rats.
    Fattore L; Spano S; Cossu G; Deiana S; Fadda P; Fratta W
    Neuropharmacology; 2005 Jun; 48(8):1097-104. PubMed ID: 15910886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological characterisation of cannabinoid receptors inhibiting interleukin 2 release from human peripheral blood mononuclear cells.
    Ihenetu K; Molleman A; Parsons M; Whelan C
    Eur J Pharmacol; 2003 Mar; 464(2-3):207-15. PubMed ID: 12620515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of cannabinoid receptor agonists on neuronally-evoked contractions of urinary bladder tissues isolated from rat, mouse, pig, dog, monkey and human.
    Martin RS; Luong LA; Welsh NJ; Eglen RM; Martin GR; MacLennan SJ
    Br J Pharmacol; 2000 Apr; 129(8):1707-15. PubMed ID: 10780977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SR 141716A acts as an inverse agonist to increase neuronal voltage-dependent Ca2+ currents by reversal of tonic CB1 cannabinoid receptor activity.
    Pan X; Ikeda SR; Lewis DL
    Mol Pharmacol; 1998 Dec; 54(6):1064-72. PubMed ID: 9855635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors.
    Terranova JP; Michaud JC; Le Fur G; Soubrié P
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):576-9. PubMed ID: 8751088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CB1 receptor activation in the basolateral amygdala produces antinociception in animal models of acute and tonic nociception.
    Hasanein P; Parviz M; Keshavarz M; Javanmardi K
    Clin Exp Pharmacol Physiol; 2007; 34(5-6):439-49. PubMed ID: 17439413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. WIN-55,212-2 and SR-141716A alter nicotine-induced changes in locomotor activity, but do not alter nicotine-evoked [3H]dopamine release.
    Rodvelt KR; Bumgarner DM; Putnam WC; Miller DK
    Life Sci; 2007 Jan; 80(4):337-44. PubMed ID: 17067637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SR141716A is an inverse agonist at the human cannabinoid CB1 receptor.
    Landsman RS; Burkey TH; Consroe P; Roeske WR; Yamamura HI
    Eur J Pharmacol; 1997 Sep; 334(1):R1-2. PubMed ID: 9346339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons.
    Huang CC; Lo SW; Hsu KS
    J Physiol; 2001 May; 532(Pt 3):731-48. PubMed ID: 11313442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cannabinoid CB1 receptor antagonist SR 141716A reverses the antiemetic and motor depressant actions of WIN 55, 212-2.
    Darmani NA
    Eur J Pharmacol; 2001 Oct; 430(1):49-58. PubMed ID: 11698062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR 141716A.
    Gifford AN; Ashby CR
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1431-6. PubMed ID: 8667207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of hippocampal acetylcholine release by cannabinoids: reversal by SR 141716A.
    Gessa GL; Mascia MS; Casu MA; Carta G
    Eur J Pharmacol; 1997 May; 327(1):R1-2. PubMed ID: 9185841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents.
    Haller J; Varga B; Ledent C; Freund TF
    Behav Pharmacol; 2004 Jul; 15(4):299-304. PubMed ID: 15252281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabinoid CB(1) receptor agonists increase rat cortical and hippocampal acetylcholine release in vivo.
    Acquas E; Pisanu A; Marrocu P; Di Chiara G
    Eur J Pharmacol; 2000 Aug; 401(2):179-85. PubMed ID: 10924924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuronal responses to cannabinoid receptor ligands in the solitary tract nucleus.
    Himmi T; Perrin J; El Ouazzani T; Orsini JC
    Eur J Pharmacol; 1998 Oct; 359(1):49-54. PubMed ID: 9831292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats.
    Zaniewska M; McCreary AC; Przegaliński E; Filip M
    Eur J Pharmacol; 2006 Jul; 540(1-3):96-106. PubMed ID: 16730696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.